Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


09.09.2019

1 Ann Thorac Surg
3 BMC Cancer
1 Br J Cancer
2 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
2 Clin Cancer Res
1 Clin Exp Metastasis
2 Clin Nucl Med
2 Int J Oncol
4 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
3 J Surg Oncol
1 J Thorac Oncol
2 JAMA Oncol
1 Lancet Infect Dis
2 Lancet Oncol
5 Lung Cancer
1 Mol Carcinog
2 Oncogene
2 PLoS One
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. EBNER PJ, Ding L, Kim AW, Atay SM, et al
    The effect of socioeconomic status on treatment and mortality in non-small cell lung cancer patients.
    Ann Thorac Surg. 2019 Aug 28. pii: S0003-4975(19)31240.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. LI L, Yan S, Zhang H, Zhang M, et al
    Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-beta1-mediated epithelial to mesenchymal transition in lung cancer cells.
    BMC Cancer. 2019;19:894.
    PubMed     Text format     Abstract available

  3. WANG L, Meng Y, Zhang QY
    LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
    BMC Cancer. 2019;19:293.
    PubMed     Text format     Abstract available

  4. GUO CY, Zhu Q, Tou FF, Wen XM, et al
    The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
    BMC Cancer. 2019;19:289.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. JETTE NR, Radhamani S, Arthur G, Ye R, et al
    Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
    Br J Cancer. 2019 Sep 4. pii: 10.1038/s41416-019-0565.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  6. TANI T, Naoki K, Yasuda H, Arai D, et al
    A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients.
    Cancer Chemother Pharmacol. 2019 Sep 6. pii: 10.1007/s00280-019-03934.
    PubMed     Text format     Abstract available

  7. SHIMADA M, Yamaguchi H, Fukuda M, Tomono H, et al
    Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
    Cancer Chemother Pharmacol. 2019 Sep 5. pii: 10.1007/s00280-019-03940.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  8. D'ANTONA P, Cattoni M, Dominioni L, Poli A, et al
    Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0626.
    PubMed     Text format     Abstract available


    Cancer Res

  9. HO MY, Liang SM, Hung SW, Liang CM, et al
    Retraction: MIG-7 Controls COX-2/PGE2-Mediated Lung Cancer Metastasis.
    Cancer Res. 2019;79:4553.
    PubMed     Text format    


    Clin Cancer Res

  10. WANG W, Huang L, Jin JY, Pi W, et al
    A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early Stage Disease.
    Clin Cancer Res. 2019 Aug 30. pii: 1078-0432.CCR-19-1202.
    PubMed     Text format     Abstract available

  11. CHANG JC, Alex D, Bott M, Tan KS, et al
    Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intra-pulmonary metastases: Comparison with standard histopathologic approach.
    Clin Cancer Res. 2019 Aug 30. pii: 1078-0432.CCR-19-1700.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  12. SUTOO S, Maeda T, Suzuki A, Kato Y, et al
    Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis.
    Clin Exp Metastasis. 2019 Sep 5. pii: 10.1007/s10585-019-09990.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  13. ANSARI-GILANI K, Yang M, Ramaiya NH
    Alveolar Sarcoidosis With Intense FDG Uptake, Mimicking Multi-focal Pneumonia and Infiltrative Lung Malignancy.
    Clin Nucl Med. 2019;44:653-654.
    PubMed     Text format     Abstract available

  14. ZHANG J, Dong A, Cui Y, Wang Y, et al
    FDG PET/CT in a Case of Primary Pulmonary Ewing Sarcoma.
    Clin Nucl Med. 2019;44:666-668.
    PubMed     Text format     Abstract available


    Int J Oncol

  15. HU C, Zhou H, Liu Y, Huang J, et al
    ROCK1 promotes migration and invasion of nonsmallcell lung cancer cells through the PTEN/PI3K/FAK pathway.
    Int J Oncol. 2019 Aug 30. doi: 10.3892/ijo.2019.4864.
    PubMed     Text format     Abstract available

  16. ZENG SG, Lin X, Liu JC, Zhou J, et al
    Hypoxiainduced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of nonsmall cell lung cancer via the P53/MDM2 signaling pathway.
    Int J Oncol. 2019 Sep 3. doi: 10.3892/ijo.2019.4867.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  17. CHO Y, Park S, Byun HK, Lee CG, et al
    Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Aug 30. pii: S0360-3016(19)33733.
    PubMed     Text format     Abstract available

  18. MA JT, Liu Y, Sun L, Milano MT, et al
    Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
    Int J Radiat Oncol Biol Phys. 2019;103:843-850.
    PubMed     Text format     Abstract available

  19. PALMA D, Daly M, Urbanic J, Giuliani M, et al
    Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
    Int J Radiat Oncol Biol Phys. 2019;103:788-791.
    PubMed     Text format    

  20. PINDER-ARABPOUR A, Jones B, Castillo R, Castillo E, et al
    Characterizing Spatial Lung Function For Esophageal Cancer Patients Undergoing Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33913.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  21. OSTHEIMER C, Evers C, Palm F, Mikolajczyk R, et al
    Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments.
    J Cancer Res Clin Oncol. 2019 Sep 6. pii: 10.1007/s00432-019-03013.
    PubMed     Text format     Abstract available


    J Surg Oncol

  22. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Text format     Abstract available

  23. LONDERO F, Morelli A, Parise O, Grossi W, et al
    Lymphadenectomy during pulmonary metastasectomy: Impact on survival and recurrence.
    J Surg Oncol. 2019;120:768-778.
    PubMed     Text format     Abstract available

  24. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  25. MORENO AC, Fellman B, Hobbs BP, Liao Z, et al
    Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2019 Aug 31. pii: S1556-0864(19)33191.
    PubMed     Text format     Abstract available


    JAMA Oncol

  26. YIN G, Zhang C
    Reanalysis of Data Comparing Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    JAMA Oncol. 2019 Sep 5. pii: 2749254. doi: 10.1001/jamaoncol.2019.3593.
    PubMed     Text format    

  27. SUN A, Hu C
    Reanalysis of Data Comparing Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer-In Reply.
    JAMA Oncol. 2019 Sep 5. pii: 2749255. doi: 10.1001/jamaoncol.2019.3602.
    PubMed     Text format    


    Lancet Infect Dis

  28. TANIWAKI M, Yamasaki M, Ishikawa N, Kawamoto K, et al
    Pulmonary cryptococcosis mimicking lung cancer.
    Lancet Infect Dis. 2019;19:1033.
    PubMed     Text format    


    Lancet Oncol

  29. CAPPUZZO F, West H
    Chemoimmunotherapy for stage IV non-small-cell lung cancer - Authors' reply.
    Lancet Oncol. 2019;20:e467.
    PubMed     Text format    

  30. UPRETY D
    Chemoimmunotherapy for stage IV non-small-cell lung cancer.
    Lancet Oncol. 2019;20:e466.
    PubMed     Text format    


    Lung Cancer

  31. YOON DW, Shin DW, Cho JH, Yang JH, et al
    Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients.
    Lung Cancer. 2019;136:115-121.
    PubMed     Text format     Abstract available

  32. ZHOU K, Jiang C, Li Q
    Cost-effectiveness analysis of pembrolizumab monotherapy and chemotherapy in the non-small-cell lung cancer with different PD-L1 tumor proportion scores.
    Lung Cancer. 2019;136:98-101.
    PubMed     Text format     Abstract available

  33. BHANDARI S, Tripathi P, Pham D, Pinkston C, et al
    Performance of community-based lung cancer screening program in a Histoplasma endemic region.
    Lung Cancer. 2019;136:102-104.
    PubMed     Text format     Abstract available

  34. DESCOURT R, Perol M, Rousseau-Bussac G, Planchard D, et al
    Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study).
    Lung Cancer. 2019;136:109-114.
    PubMed     Text format     Abstract available

  35. AREDO JV, Padda SK, Kunder CA, Han SS, et al
    Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".
    Lung Cancer. 2019 Aug 26. pii: S0169-5002(19)30621.
    PubMed     Text format    


    Mol Carcinog

  36. SUN W, Hu S, Zu Y, Deng Y, et al
    KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer.
    Mol Carcinog. 2019 Sep 5. doi: 10.1002/mc.23072.
    PubMed     Text format     Abstract available


    Oncogene

  37. ZENG F, Wang Q, Wang S, Liang S, et al
    Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0984.
    PubMed     Text format     Abstract available

  38. LIN SC, Lin CH, Shih NC, Liu HL, et al
    Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0994.
    PubMed     Text format     Abstract available


    PLoS One

  39. YU S, Choi HH, Kim IW, Kim TJ, et al
    Conditioned medium from asbestos-exposed fibroblasts affects proliferation and invasion of lung cancer cell lines.
    PLoS One. 2019;14:e0222160.
    PubMed     Text format     Abstract available

  40. PAIK SH, Yeo CD, Jeong JE, Kim JS, et al
    Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer.
    PLoS One. 2019;14:e0220127.
    PubMed     Text format     Abstract available


    Thorax

  41. BALATA H, Tonge J, Barber PV, Colligan D, et al
    Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
    Thorax. 2019 Sep 3. pii: thoraxjnl-2018-212601.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: